Urinary metabolomic analysis to detect changes after intravenous, non-ionic, low osmolar iodinated radiocontrast for computerized tomographic imaging

Deborah B. Diercks, Kelly P. Owen, Vladimir Tolstikov, Mark E. Sutter, Jeffrey A. Kline

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Contrast-induced nephropathy is a result of injury to the proximal tubules caused by oxidative stress and ischemia. Metabolomics is a novel technique that has been used to identify renal damage from drug toxicities. The objective of this study is to analyze the metabolic changes in the urine after dosing with intravenous (IV) contrast for computed tomograph (CT) of the chest.

METHODS: A convenience sample of patients undergoing a chest ct with iv contrast who had at least one of the following: age ≥50 years, diabetes, heart failure, chronic kidney disease, coronary artery disease, or diastolic blood pressure >90 mmHg -- were eligible for enrollment. Urine samples were collected prior to imaging and 4-6 hours post imaging. Samples underwent gas chromography/mass spectrometry profiling. We measured peak metabolite values and log transformed data. Paired T tests were calculated. We used significance analysis of microarrays (SAM) to determine the most significant metabolites.

RESULTS: The cohort comprised 14 patients with matched samples; 9/14 (64.3) were males, and the median age was 61 years (IQR 50-68). A total of 158 metabolites were identified. Using SAM we identified 9 metabolites that were identified as significant using a delta of 1.6.

CONCLUSION: Changes in urinary metabolites are present soon after contrast administration. This change in urinary metabolites may be potential early identifiers of contrast-induced nephropathy and could identify patients at high-risk for developing this condition.

Original languageEnglish (US)
Pages (from-to)152-157
Number of pages6
JournalWestern Journal of Emergency Medicine
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

Fingerprint

Metabolomics
Microarray Analysis
Thorax
Urine
Blood Pressure
Drug-Related Side Effects and Adverse Reactions
Chronic Renal Insufficiency
Coronary Artery Disease
Mass Spectrometry
Oxidative Stress
Ischemia
Heart Failure
Gases
Kidney
Wounds and Injuries

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Urinary metabolomic analysis to detect changes after intravenous, non-ionic, low osmolar iodinated radiocontrast for computerized tomographic imaging. / Diercks, Deborah B.; Owen, Kelly P.; Tolstikov, Vladimir; Sutter, Mark E.; Kline, Jeffrey A.

In: Western Journal of Emergency Medicine, Vol. 15, No. 2, 01.03.2014, p. 152-157.

Research output: Contribution to journalArticle

@article{4949ea2759054f1797b202ef33557fdb,
title = "Urinary metabolomic analysis to detect changes after intravenous, non-ionic, low osmolar iodinated radiocontrast for computerized tomographic imaging",
abstract = "INTRODUCTION: Contrast-induced nephropathy is a result of injury to the proximal tubules caused by oxidative stress and ischemia. Metabolomics is a novel technique that has been used to identify renal damage from drug toxicities. The objective of this study is to analyze the metabolic changes in the urine after dosing with intravenous (IV) contrast for computed tomograph (CT) of the chest.METHODS: A convenience sample of patients undergoing a chest ct with iv contrast who had at least one of the following: age ≥50 years, diabetes, heart failure, chronic kidney disease, coronary artery disease, or diastolic blood pressure >90 mmHg -- were eligible for enrollment. Urine samples were collected prior to imaging and 4-6 hours post imaging. Samples underwent gas chromography/mass spectrometry profiling. We measured peak metabolite values and log transformed data. Paired T tests were calculated. We used significance analysis of microarrays (SAM) to determine the most significant metabolites.RESULTS: The cohort comprised 14 patients with matched samples; 9/14 (64.3) were males, and the median age was 61 years (IQR 50-68). A total of 158 metabolites were identified. Using SAM we identified 9 metabolites that were identified as significant using a delta of 1.6.CONCLUSION: Changes in urinary metabolites are present soon after contrast administration. This change in urinary metabolites may be potential early identifiers of contrast-induced nephropathy and could identify patients at high-risk for developing this condition.",
author = "Diercks, {Deborah B.} and Owen, {Kelly P.} and Vladimir Tolstikov and Sutter, {Mark E.} and Kline, {Jeffrey A.}",
year = "2014",
month = "3",
day = "1",
doi = "10.5811/westjem.2013.11.15343",
language = "English (US)",
volume = "15",
pages = "152--157",
journal = "Western Journal of Emergency Medicine",
issn = "1936-900X",
publisher = "University of California",
number = "2",

}

TY - JOUR

T1 - Urinary metabolomic analysis to detect changes after intravenous, non-ionic, low osmolar iodinated radiocontrast for computerized tomographic imaging

AU - Diercks, Deborah B.

AU - Owen, Kelly P.

AU - Tolstikov, Vladimir

AU - Sutter, Mark E.

AU - Kline, Jeffrey A.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - INTRODUCTION: Contrast-induced nephropathy is a result of injury to the proximal tubules caused by oxidative stress and ischemia. Metabolomics is a novel technique that has been used to identify renal damage from drug toxicities. The objective of this study is to analyze the metabolic changes in the urine after dosing with intravenous (IV) contrast for computed tomograph (CT) of the chest.METHODS: A convenience sample of patients undergoing a chest ct with iv contrast who had at least one of the following: age ≥50 years, diabetes, heart failure, chronic kidney disease, coronary artery disease, or diastolic blood pressure >90 mmHg -- were eligible for enrollment. Urine samples were collected prior to imaging and 4-6 hours post imaging. Samples underwent gas chromography/mass spectrometry profiling. We measured peak metabolite values and log transformed data. Paired T tests were calculated. We used significance analysis of microarrays (SAM) to determine the most significant metabolites.RESULTS: The cohort comprised 14 patients with matched samples; 9/14 (64.3) were males, and the median age was 61 years (IQR 50-68). A total of 158 metabolites were identified. Using SAM we identified 9 metabolites that were identified as significant using a delta of 1.6.CONCLUSION: Changes in urinary metabolites are present soon after contrast administration. This change in urinary metabolites may be potential early identifiers of contrast-induced nephropathy and could identify patients at high-risk for developing this condition.

AB - INTRODUCTION: Contrast-induced nephropathy is a result of injury to the proximal tubules caused by oxidative stress and ischemia. Metabolomics is a novel technique that has been used to identify renal damage from drug toxicities. The objective of this study is to analyze the metabolic changes in the urine after dosing with intravenous (IV) contrast for computed tomograph (CT) of the chest.METHODS: A convenience sample of patients undergoing a chest ct with iv contrast who had at least one of the following: age ≥50 years, diabetes, heart failure, chronic kidney disease, coronary artery disease, or diastolic blood pressure >90 mmHg -- were eligible for enrollment. Urine samples were collected prior to imaging and 4-6 hours post imaging. Samples underwent gas chromography/mass spectrometry profiling. We measured peak metabolite values and log transformed data. Paired T tests were calculated. We used significance analysis of microarrays (SAM) to determine the most significant metabolites.RESULTS: The cohort comprised 14 patients with matched samples; 9/14 (64.3) were males, and the median age was 61 years (IQR 50-68). A total of 158 metabolites were identified. Using SAM we identified 9 metabolites that were identified as significant using a delta of 1.6.CONCLUSION: Changes in urinary metabolites are present soon after contrast administration. This change in urinary metabolites may be potential early identifiers of contrast-induced nephropathy and could identify patients at high-risk for developing this condition.

UR - http://www.scopus.com/inward/record.url?scp=84945368828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945368828&partnerID=8YFLogxK

U2 - 10.5811/westjem.2013.11.15343

DO - 10.5811/westjem.2013.11.15343

M3 - Article

VL - 15

SP - 152

EP - 157

JO - Western Journal of Emergency Medicine

JF - Western Journal of Emergency Medicine

SN - 1936-900X

IS - 2

ER -